Back to portfolio
Liminal BioSciences (www.liminalbiosciences.com) has as goal the validation of 5-oxo-ETE as an important mediator of eosinophilic inflammation. Picomolar, orally-available antagonists have been discovered and shown to block eosinophil infiltration into sites of inflammation in non-human primate models of asthma.